Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             89 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acid suppressants reduce the therapeutic effect of immune checkpoint inhibitors and increase the risk of acute kidney injury: a meta-analysis Okamoto, Keisuke

10 p. 1343-1353
artikel
2 A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study) Fujiwara, Hiroyuki
2019
10 p. 1284-1291
artikel
3 A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma Tahara, Makoto

10 p. 1812-1821
artikel
4 A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer Takahashi, Shunji

10 p. 1977-1985
artikel
5 Artificial intelligence predicts lymph node metastasis or risk of lymph node metastasis in T1 colorectal cancer Kasahara, Kenta

10 p. 1570-1579
artikel
6 A single-arm, phase 2 study of steroid-containing mouthwash for the prevention of everolimus-associated stomatitis in multiple tumor types Hattori, Masaya
2019
10 p. 1320-1327
artikel
7 Assessment of surgical outcomes of off-clamp open partial nephrectomy without renorrhaphy for ≥T1b renal tumours Nakamura, Masaki

10 p. 1955-1960
artikel
8 Cellular immunotherapy plus chemotherapy ameliorates survival in gastric cancer patients: a meta-analysis Hu, Guoming

10 p. 1747-1756
artikel
9 Change of HPV vaccination rates in Japan: the effect of individual notifications implemented by local governments Yagi, Asami

10 p. 1651-1659
artikel
10 Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022 Ishikura, Kenji

10 p. 1333-1342
artikel
11 Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022 Muto, Satoru

10 p. 1259-1297
artikel
12 Chapter 2:indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022 Nishiyama, Hiroyuki

10 p. 1298-1314
artikel
13 Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022 Ando, Yuichi

10 p. 1315-1332
artikel
14 Clinical significance of intraperitoneal paclitaxel combined with systemic chemotherapy for gastric cancer with peritoneal metastasis Nakashima, Taiki

10 p. 1371-1377
artikel
15 Clinical significance of metastatic tumor deposit foci in rectal cancer in the lateral pelvic lymph node area Yamai, Daisuke

10 p. 1388-1397
artikel
16 Clinical significance of prognostic nutritional index (PNI) in malignant melanoma Mirili, Cem
2019
10 p. 1301-1310
artikel
17 Clinical significance of the pattern-based classification in endocervical adenocarcinoma, usual and variants Byun, Jung Mi
2019
10 p. 1264-1272
artikel
18 Clinicopathological characteristics and prognosis analysis of ovarian metastases in colorectal cancer: a single-center experience Zhou, Rui

10 p. 1822-1829
artikel
19 Clinicopathological features of sporadic MSI colorectal cancer and Lynch syndrome: a single-center retrospective cohort study Nakayama, Yujiro

10 p. 1881-1889
artikel
20 Comparison of 2- and 4-week S-1 administration as adjuvant chemotherapy for advanced gastric cancer Ogawa, Koichi

10 p. 1807-1813
artikel
21 Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study Gökyer, Ali

10 p. 1757-1762
artikel
22 Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1 Nishio, Makoto

10 p. 1369-1370
artikel
23 Correction to: Recent advances of the regulation roles of MicroRNA in glioblastoma Yan, Chengrui

10 p. 1879
artikel
24 Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis Aalami, Amir Hossein

10 p. 1605-1615
artikel
25 Diverting ileostomy is a risk factor for renal impairment during CAPOX therapy Okamoto, Kazuaki

10 p. 1616-1623
artikel
26 Effects and risk factors of TAS-102 in real-world patients with metastatic colorectal cancer, EROTAS-R study Yoshida, Naohisa

10 p. 1378-1387
artikel
27 Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer Yoshihama, Tomoko

10 p. 1644-1650
artikel
28 Efficacy of local salvage therapy for recurrent uterine cervical cancer after definitive radiotherapy Hiraoka, Shinya

10 p. 1968-1976
artikel
29 Elevated expression of the RNA‐binding motif protein 43 predicts poor prognosis in esophageal squamous cell carcinoma Li, Yong

10 p. 1847-1855
artikel
30 Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or HPV infection Onuma, Toshimichi

10 p. 1854-1860
artikel
31 Familial cancer of unknown primary Rassy, Elie
2019
10 p. 1328-1331
artikel
32 First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1 Nishio, Makoto

10 p. 1354-1368
artikel
33 Focal therapy with high-intensity focused ultrasound for the localized prostate cancer for Asian based on the localization with MRI-TRUS fusion image-guided transperineal biopsy and 12-cores transperineal systematic biopsy: prospective analysis of oncological and functional outcomes Shoji, Sunao

10 p. 1844-1853
artikel
34 Frailty is associated with poor prognosis after resection for pancreatic cancer Mima, Kosuke

10 p. 1938-1946
artikel
35 Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy Kibe, Yuichi
2019
10 p. 1182-1189
artikel
36 Fusobacterium nucleatum load in MSI colorectal cancer subtypes Ono, Tomoyuki

10 p. 1580-1588
artikel
37 Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study Uemura, Hiroji

10 p. 1632-1643
artikel
38 Hereditary pancreatic cancer Abe, Kodai

10 p. 1784-1792
artikel
39 High expression of miR-195 is related to favorable prognosis in cytogenetically normal acute myeloid leukemia Cui, Longzhen

10 p. 1986-1993
artikel
40 Immune checkpoint inhibitor-induced sarcoidosis-like granulomas Rambhia, Pooja H.
2019
10 p. 1171-1181
artikel
41 Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer Abe, Kyohei

10 p. 1929-1937
artikel
42 Impact of positive surgical margin status in predicting early biochemical recurrence after robot-assisted radical prostatectomy Morizane, Shuichi

10 p. 1961-1967
artikel
43 Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective study Nakano, Shintaro

10 p. 1800-1806
artikel
44 Incidence and risk factors of parastomal hernia after ileal conduit diversion in Japanese population Maruo, Kazutaka

10 p. 1830-1834
artikel
45 Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck Nishimura, Ari

10 p. 1822-1830
artikel
46 Interim analysis for post-marketing surveillance of dabrafenib and trametinib combination therapy in Japanese patients with unresectable and metastatic melanoma with BRAF V600 mutation Teshima, Yasutomo

10 p. 1870-1878
artikel
47 Intracellular accumulation of PD-1 molecules in circulating T lymphocytes in advanced malignant melanoma: an implication for immune evasion mechanism Takahashi, Ryo

10 p. 1861-1869
artikel
48 Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition Mishima, Saori

10 p. 1237-1258
artikel
49 Late start and insufficient S-1 dose in adjuvant chemotherapy can lead to poor prognosis in stage II/III gastric cancer Miyatani, Kozo
2019
10 p. 1190-1196
artikel
50 Long-term cognitive outcome in adult survivors of an early childhood posterior fossa brain tumour Wagner, Adam P.

10 p. 1763-1773
artikel
51 Lymphocyte–C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma Yugawa, Kyohei

10 p. 1901-1910
artikel
52 Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma Iseda, Norifumi

10 p. 1890-1900
artikel
53 Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study) Suzuki, Nobuaki
2019
10 p. 1223-1230
artikel
54 Osteogenic and brain metastases after non-small cell lung cancer resection Mizuno, Tetsuya

10 p. 1840-1846
artikel
55 Outcome of patients with newly diagnosed primary CNS lymphoma after high-dose methotrexate followed by consolidation whole-brain radiotherapy and cytarabine: an 8-year cohort study Piriyakhuntorn, Pokpong

10 p. 1805-1811
artikel
56 Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study Baba, Tsukasa

10 p. 1411-1420
artikel
57 Percutaneous cryoablation combined with prior transcatheter arterial embolization for renal cell carcinomas of 3 cm or larger: a prospective study Gobara, Hideo

10 p. 1589-1595
artikel
58 Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study) Okano, Naohiro

10 p. 1835-1843
artikel
59 Phase II multi-institutional prospective trial of nab-paclitaxel as second-line chemotherapy for advanced gastric cancer refractory to fluoropyrimidine with modified dose reduction criteria (CCOG1303) Kobayashi, Daisuke

10 p. 1793-1799
artikel
60 Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER) Moriwaki, Toshikazu
2019
10 p. 1214-1222
artikel
61 Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer Shikama, Ayumi
2019
10 p. 1256-1263
artikel
62 Prevalence of pathogenic germline variants in the circulating tumor DNA testing Yamamoto, Yoshihiro

10 p. 1554-1561
artikel
63 Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era Naito, Sei

10 p. 1947-1954
artikel
64 Prognostic factors and survival in Japanese patients with brain metastasis from renal cell cancer Takeshita, Nobushige
2019
10 p. 1231-1237
artikel
65 Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma Wakamatsu, Toru
2019
10 p. 1311-1319
artikel
66 Protective effect of the oral administration of cystine and theanine on oxaliplatin-induced peripheral neuropathy: a pilot randomized trial Kobayashi, Minoru

10 p. 1814-1821
artikel
67 Radiotherapy role in non-seminomatous germ cell tumors, radiobiological and technical issues of an unexplored scenario Francolini, Giulio

10 p. 1777-1783
artikel
68 Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701 Kawase, Tomono

10 p. 1871-1880
artikel
69 Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study Kato, Taigo

10 p. 1596-1604
artikel
70 Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma Ogawa, Koichi

10 p. 1856-1863
artikel
71 Retrospective study of the efficacy and safety of docetaxel/carboplatin combination therapy as postoperative adjuvant chemotherapy for nonsquamous cell carcinoma of the cervix Koike, Ryo

10 p. 1421-1430
artikel
72 Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center Heudel, Pierre-Etienne

10 p. 1793-1804
artikel
73 SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis Sasahira, Tomonori

10 p. 1831-1839
artikel
74 Serum zinc deficiency in patients after gastrectomy for gastric cancer Namikawa, Tsutomu

10 p. 1864-1870
artikel
75 Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A) Sasaki, Shun
2019
10 p. 1204-1213
artikel
76 Surgical and functional outcomes of robot-assisted laparoscopic partial nephrectomy for renal cell carcinoma in adolescents and young adults: a propensity score matching study Yoshida, Kazuhiko

10 p. 1624-1631
artikel
77 Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas Safi, S. A.

10 p. 1911-1921
artikel
78 Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study Mitani, Seiichiro
2019
10 p. 1197-1203
artikel
79 Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation Aizawa, Rihito
2019
10 p. 1247-1255
artikel
80 The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan Kawakita, Daisuke

10 p. 1774-1785
artikel
81 The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer Taniai, Tomohiko

10 p. 1922-1928
artikel
82 The role of anti-tumor immunity of focused ultrasound for the malignancies: depended on the different ablation categories Zhang, Luping

10 p. 1543-1553
artikel
83 The tumor suppressor function of hsa_circ_0006282 in gastric cancer through PTEN/AKT pathway Li, Zhe

10 p. 1562-1569
artikel
84 Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinoma Takasaki, Kazuki
2019
10 p. 1273-1283
artikel
85 Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer Pak, Sahyun
2019
10 p. 1238-1246
artikel
86 Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study Nishiyama, Hiroyuki

10 p. 1398-1410
artikel
87 Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma Tatsumi, Mitsuaki
2019
10 p. 1292-1300
artikel
88 Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter study Yoshihara, Masato

10 p. 1660-1668
artikel
89 Why is renal impairment associated with poorer cancer specific survival in breast cancer patients?: a comparison with patients with other comorbidities Evans, Andy

10 p. 1786-1792
artikel
                             89 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland